Brown Advisory’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $626K | Sell |
|
|||||
|
2021
Q1 | $528K | Buy |
|
|||||
|
2020
Q4 | $424K | Buy |
|
|||||
|
2020
Q3 | $268K | Sell |
|
|||||
|
2020
Q2 | $555K | Buy |
|
|||||
|
2020
Q1 | $336K | Buy |
|
|||||
|
2019
Q4 | $236K | Sell |
|
|||||
|
2019
Q3 | $218K | Sell |
|
|||||
|
2019
Q2 | $298K | Sell |
|
|||||
|
2019
Q1 | $2.45M | Buy |
|
|||||
|
2018
Q4 | $1.33M | Sell |
|
|||||
|
2018
Q3 | $3.31M | Buy |
|
|||||
|
2018
Q2 | $2.52M | Buy |
|
|||||
|
2018
Q1 | $567K | Buy |
|
|||||
|
2017
Q4 | $577K | Sell |
|
|||||
|
2017
Q3 | $960K | Sell |
|
|||||
|
2017
Q2 | $1.75M | Sell |
|
|||||
|
2017
Q1 | $304M | Sell |
|
|||||
|
2016
Q4 | $396M | Sell |
|
|||||
|
2016
Q3 | $475M | Buy |
|
|||||
|
2016
Q2 | $356M | Buy |
|
|||||
|
2016
Q1 | $343M | Buy |
|
|||||
|
2015
Q4 | $426M | Buy |
|
|||||
|
2015
Q3 | $297M | Buy |
|
|||||
|
2015
Q2 | $274M | Buy |
|
|||||
|
2015
Q1 | $9.25M | Buy |
|